Immunology
3 drugs are in development for Lupus Nephritis.
- Companies
- 3
- Clinical trials
- 30
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Lupus Nephritis pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| Felzartamab | BIOGEN INC. (BIIB) |
Phase 2(1)
| Drug | Company |
|---|---|
| FT819 | FATE THERAPEUTICS INC (FATE) |
Phase 4(1)
| Drug | Company |
|---|---|
| LUPKYNIS | Aurinia Pharmaceuticals Inc. (AUPH) |
About this indication
Lupus Nephritis context
Immunology·MeSH: Lupus Nephritis (D008181)
Also known as: Glomerulonephritides, Lupus, Glomerulonephritis, Lupus, Lupus Nephritides
Compare drugs
Frequently asked questions
How many drugs are in development for Lupus Nephritis?
BioSniper tracks 3 drugs in development for Lupus Nephritis across 3 companies.
How many clinical trials target Lupus Nephritis?
There are 30 clinical trials targeting Lupus Nephritis tracked by BioSniper.